Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,249.51
+13.090.40%
Number of Gainers:19
Number of Losers:10
Number of Flat:2
PE:- -
High:3,262.57
Open:3,236.72
Low:3,231.31
Close:3,236.42
Volume:315.28M
Turnover:40.91B
Market Cap:6.16T
Float Cap:5.44T

Loading ...

US 10-Year Treasury Yield Breaks 5%, Testing Corporate Earnings Strength, but JPMorgan Stays Firm: Stocks Will Remain the Portfolio Growth Engine

Stock News
·
Sep 24

BlackBerry Lifts Annual Revenue Forecast on Strength in Automotive Software Business

Reuters
·
Sep 24

Merck's Drug for Diabetes-Related Eye Disease Meets Trial Goal

Reuters
·
Sep 24

Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection

Dow Jones
·
Sep 24

Oracle, Wild Bioscience Collaborate on AI-Driven Agriculture Research Using Oracle Cloud, IoT

Reuters
·
Sep 24

Musk Expands Business Empire Across the American Sun Belt with Massive Investments

Deep News
·
Sep 24

Merck Says Remigromig Meets Primary Endpoint in Pivotal Brunello Trial for Diabetic Macular Edema

Reuters
·
Sep 24

Eli Lilly - Onswik Kwikpen to be Available in U.S. in 500 Units/Ml and 1,000 Units/Ml Concentrations

THOMSON REUTERS
·
Sep 24

U.S. Food and Drug Administration (FDA) Approves Lilly's Onswik™ (Insulin Efsitora Alfa-Gobe), a Once-Weekly Basal Insulin Injection Treatment for Adults Living with Type 2 Diabetes

THOMSON REUTERS
·
Sep 24

Merck & Co - Higher Rates of Pdr, Vitreous Hemorrhage, and Discontinuations with Remigromig

THOMSON REUTERS
·
Sep 24

Merck’s Remigromig, a Tri-Specific Agonist of the Wingless-Related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2B/3 Brunello Study of Adults with Diabetic Macular Edema

THOMSON REUTERS
·
Sep 24

Merck & Co Inc: Both Doses of Remigromig were Generally Well Tolerated

THOMSON REUTERS
·
Sep 24

Merck & Co - Both Remigromig Doses Show Non-Inferiority to Ranibizumab at 52 Weeks

THOMSON REUTERS
·
Sep 24

Amazon Launches New AI Product, Reflecting Industry-Wide Price Cuts

Deep News
·
Sep 24

Microsoft's Brad Smith Says AI Needs an Emergency Kill Switch

Deep News
·
Sep 24

Lockheed Martin (LMT) Looks Undervalued in a Long Restocking Cycle

TIPRANKS
·
Sep 24

Tesla FSD Flagged for Speeding, Unsafe Maneuvers in Independent Brussels Test

MT Newswires Live
·
Sep 24

KBR Names Michael LaRouche CEO-Designate of Planned Trinzic Spinoff

Reuters
·
Sep 24

Black Monday's Stock-Market Warning Signal Came from the Bond Market, and It's Back, Says Wall Street Veteran

Dow Jones
·
Sep 24

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

GlobeNewswire
·
Sep 24